IL5 and Alzheimer disease: As compared to the AD group, the AD+CA-80 and AD+CA-200 groups exhibited substantially inhibited the expression of IL-5 and IL-10 (reduced by 5.6- and 11.5-fold, respectively), as well as that of IL-10 mRNA level by 3.2- and 9.5-fold, respectively.